ea0034s6.3 | Thyroid cell biology comes to your clinic (Supported by <emphasis role="italic">Journal of Molecular Endocrinology</emphasis>) | SFEBES2014
McCabe Chris
Most of the oncogenic events in thyroid cancer are known, and the pathways which govern thyroid cell proliferation have been exquisitely mapped. However, existing knowledge does not fully explain the genetic complexity of thyroid cancer, or reveal whether tumours are likely to be benign, malignant, or resistant to treatment. Whilst mutations and chromosomal rearrangements are central to the aetiology of DTC, the altered expression of proto-oncogenes and tumour suppressor genes...